Authors:
Au, JLS
Badalament, RA
Wientjes, MG
Young, DC
Warner, JA
Venema, PL
Pollifrone, DL
Harbrecht, JD
Chin, JL
Lerner, SP
Miles, BJ
Citation: Jls. Au et al., Methods to improve efficacy of intravesical mitomycin C: Results of a randomized phase III trial, J NAT CANC, 93(8), 2001, pp. 597-604
Citation: Jls. Au et Mg. Wientjes, Re: Methods to improve efficacy of intravesical mitomycin C: Results of a randomized phase III trial - Response, J NAT CANC, 93(20), 2001, pp. 1575-1575
Authors:
Gan, YB
Mo, YQ
Kalns, JE
Lu, J
Danenberg, K
Danenberg, P
Wientjes, MG
Au, JLS
Citation: Yb. Gan et al., Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin c activity in human bladder tumors, CLIN CANC R, 7(5), 2001, pp. 1313-1319
Authors:
Li, D
Gan, YB
Wientjes, MG
Badalament, RA
Au, JLS
Citation: D. Li et al., Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: Cytochrome P450 oxidoreductase in bladder tissues and tumors, J UROL, 166(6), 2001, pp. 2500-2505
Citation: Sh. Jang et al., Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: Effect of treatment schedule, J PHARM EXP, 296(3), 2001, pp. 1035-1042
Citation: Nj. Millenbaugh et al., A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect, CANC CHEMOT, 45(4), 2000, pp. 265-272
Citation: Sh. Song et al., Fibroblast growth factors: An epigenetic mechanism of broad spectrum resistance to anticancer drugs, P NAS US, 97(15), 2000, pp. 8658-8663
Citation: I. Knemeyer et al., Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment, CANC CHEMOT, 44(3), 1999, pp. 241-248